Company / FCF Margin
Unicycive Therapeutics, Inc. FCF Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-2710.4%
FY2024
5-year range
-2710.4% / -609.5%
FY2022-FY2024
Trend
-64.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -609.5% to -2710.4% over the past 2 years.
Based on SEC 10-K filings.
-2710.4% in FY2024.
Declined from -609.5% to -2710.4% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin decreased 64.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -2710.4% | -64.7% |
| FY2023 | -1645.9% | -170.1% |
| FY2022 | -609.5% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026